Gregory I. Frost
2013
In 2013, Gregory I. Frost earned a total compensation of $1.5M as Former President and Chief Executive Officer at Halozyme Therapeutics, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $544,583 |
|---|---|
| Option Awards | $259,721 |
| Salary | $453,819 |
| Stock Awards | $255,450 |
| Other | $2,993 |
| Total | $1,516,566 |
Frost received $544.6K in non-equity incentive plan, accounting for 36% of the total pay in 2013.
Frost also received $259.7K in option awards, $453.8K in salary, $255.5K in stock awards and $3K in other compensation.
Rankings
In 2013, Gregory I. Frost's compensation ranked 4,884th out of 12,286 executives tracked by ExecPay. In other words, Frost earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,884 out of 12,286 | 60th |
Division Manufacturing | 1,687 out of 4,612 | 63rd |
Major group Chemicals And Allied Products | 484 out of 1,462 | 67th |
Industry group Drugs | 341 out of 1,156 | 71st |
Industry Biological Products, Except Diagnostic Substances | 52 out of 196 | 74th |
Source: SEC filing on April 3, 2015.
Frost's colleagues
We found five more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2013.
2013
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
2013
James Shaffer
Halozyme Therapeutics
Former Vice President and Chief Commercial Officer
2013
Jean Liu
Halozyme Therapeutics
General Counsel
2013
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2013
Kurt Gustafson
Halozyme Therapeutics